Research on viral diseases and the response to them. Covers Ebola and mpox, diagnostics, post-viral fatigue, and outbreak control strategies.
Researchers have found that a specific protein modification to the immune protein MDA5 can block viral replication and reduce heart inflammation. The study's findings could lead to the development of broad-spectrum antiviral treatments that target multiple viruses.
Researchers found that full-genome differences between rotavirus strains influence vaccine effectiveness, highlighting the need for a broader approach to vaccine design. The study's results suggest that vaccines should be designed based on the whole genome of circulating strains, rather than just two surface proteins.
Researchers have made significant discoveries about the role of GP38 in viral infections and pathogenesis, highlighting its potential as a target for vaccines and medical countermeasures. Non-neutralizing GP38-specific antibodies have shown protective efficacy against lethal challenge, reducing circulating GP38 and vascular leak.
A single mutation in the spike protein of western equine encephalitis virus is enough to prevent it from attaching to human and horse cells. However, a change in the viral spike protein enables WEEV strains to attach to a different receptor, found on mammalian brain cells, which is shared by its cousin eastern equine encephalitis virus.
Researchers have discovered a protective cloaking mechanism in jumbo phages that shield their genetic material from the host's immune system. This innovation could lead to new therapies for antibiotic-resistant infections.
Researchers at the University of Surrey warn that mpox's sustained human-to-human transmission poses a significant risk to global health. The virus can cause a painful rash, fever, and swollen glands, and has the potential to spread among children, who are at greater risk of serious illness.
A new study reveals that the presence of Nora virus in laboratory strains of Drosophila fruit flies can increase their sensitivity to bacterial infection and limit their lifespan. Flies with persistent viral infections have higher stem cell growth rates, making them more susceptible to secondary pathogenic infections.
A cross-sectional study found that hospitalized adults with RSV vaccine eligibility were more likely to receive the vaccine. Sociodemographic differences in vaccine uptake occurred, suggesting appropriate prioritization of populations with increased risk.
A study by Ann & Robert H Lurie Children's Hospital of Chicago strongly suggests that Kawasaki disease is caused by a single respiratory virus that has yet to be identified. The research found inclusion bodies in tissue samples from 20 years, indicating a common virus, and contradicting the theory of multiple pathogens.
Researchers tested various disinfectants to inactivate hepatitis A virus particles, finding only a few effective agents. The study suggests that surface disinfection could help prevent infection, especially in high-risk areas.
Larvae of wood frogs grow and mature precociously when infected with ranavirus, exhibiting accelerated growth and development. This may help tadpoles tolerate the energetic demands of infection or escape risky environments to avoid infection entirely.
A recent study reveals how Epstein-Barr virus (EBV) aggravates ulcerative colitis (UC) through macrophage pyroptosis, a form of inflammatory cell death. EBV infection accelerates glycolysis, leading to increased inflammation and intestinal damage in UC patients.
Scientists at Johns Hopkins Medicine discovered how bacteria protect themselves from certain phage invaders by seizing genetic material from weakened, dormant phages and forming a biological 'memory' that their offspring inherit. This process allows the bacteria to recognize and fight off similar viruses in the future.
A groundbreaking study reveals a complete antiviral immune pathway in rice plants that recognizes viral coat proteins, degrades signaling pathways, and activates RNA silencing and reactive oxygen species to fend off viruses. This discovery paves the way for developing multi-target strategies for antiviral breeding of crops.
A recent study identifies 11 natural compounds that can inhibit the SARS-CoV-2 spike protein, including caffeine, which exhibits high binding stability and excellent solubility. The discovery highlights the potential of natural products in combating COVID-19 and demonstrates the versatility of widely known compounds like caffeine.
Researchers at Martin-Luther-Universität Halle-Wittenberg have developed a new avenue to combat the Cucumber mosaic virus by directing the plant's natural defences. The RNA-based active agents have shown high efficacy in laboratory experiments, protecting 80-100% of treated plants from infection.
Researchers at Penn State discovered that Zika virus builds tiny tunnels called tunneling nanotubes to transport material needed to infect nearby cells, including in placental cells. This allows the virus to cross the placental barrier without raising alarm in the immune system.
Scientists at St. Jude Children's Research Hospital found that frequently used flu antivirals do not work well against the H5N1 avian influenza virus in cows' milk. The study showed that reducing infection risk through methods like avoiding raw milk and minimizing dairy farm workers' exposures may be more effective interventions.
A study found that RSV hospitalization rates increase progressively with age among older adults in Spain, with those over 85 years old facing the highest risk. Certain chronic conditions, such as blood cancer, COPD, and cardiovascular disease, also significantly increase the risk of hospitalization.
A new study published in PLOS Medicine estimates that the COVID-19 pandemic cost Europe 16.8 million disability-free years of life between 2020 and 2022. The study found that more than half of these lost years would have been lived without disability, highlighting the pandemic's long-term impact on older populations.
Research finds that certain viral antibodies and genetic risk factors can increase MS risk, with elevated antibody levels combined with a specific gene variant associated with strong increased risk. The study also identifies potential biomarkers for early diagnosis.
A study published in Human Gene Therapy found that over half of individuals with Niemann-Pick disease type C1 lacked neutralizing antibodies against AAV2 and AAV9. This absence of antibodies may impact the effectiveness of gene therapy treatments for this rare disorder.
Eradivir's EV25 is a small molecule immunotherapy biotech company developing treatments for influenza. The Phase 2 challenge study will gather safety and efficacy data from healthy participants infected with influenza.
Researchers at Aalto University and others have developed a model that shows smartwatches can accurately detect viral infections several days before symptoms appear. This early detection can lead to significant reductions in disease transmission and could potentially stop a pandemic before it starts.
A longitudinal study found that EBV infection predisposes people to develop Crohn's disease, with a five-to-seven-year delay between exposure and diagnosis. The study suggests that EBV may alter the immune system leading to Crohn's disease.
The influenza vaccine provided moderate protection against influenza A strains, but strong protection against influenza B. The vaccine was most effective in preventing severe disease among children and adolescents, with a high effectiveness rate.
Enodia Therapeutics, launched by Institut Pasteur and Argobio, leverages AI to develop selective inhibitors of the Sec61/translocon molecular complex for treating cancer, inflammatory diseases, and viral infections. The company's breakthrough technology has earned a prestigious Golden Ticket Award from Pfizer.
A study suggests that pre-existing immunity against seasonal H1N1 flu can reduce the severity of bird flu in ferrets. In the study, ferrets with prior H1N1 immunity were protected against severe disease and death caused by H5N1 bird flu, whereas those without prior immunity had more severe illness and fatal outcomes.
A new integrated 3D imaging approach has revealed exquisite detail of the virus assembly process used by herpes simplex virus during replication. The research identified previously unknown functions of HSV-1 structural proteins and provided insights into the unmutated gene's usual role in viral assembly.
Researchers analyzed protein-coding RNA transcripts from single cells and lung fluid of infected pigs, monitoring immune cell alterations triggered by PRRSV strains of varying virulence. They found that high-virulence PRRSV caused severe lung damage and immune imbalance, while less virulent strains led to delayed lung damage with fewer...
A new study led by La Jolla Institute for Immunology scientists found that children who experience multiple dengue virus infections develop protective T cells, which help fight the virus. These T cells appear to be key to dengue virus immunity and may inform the development of a vaccine that prompts a similar response.
A preclinical trial has uncovered how beta-glucan can 'reprogram' immune cells to prevent lung inflammation and reduce the risk of illness and death from influenza. The study's findings highlight beta-glucan as a promising therapy for influenza and other emerging viral pathogens.
A new retrospective study found that nearly half of patients with fever of unknown origin in sub-Saharan Africa had a detectable pathogen, including bacterial strains and hemorrhagic fever viruses. The study highlights the need for strengthened laboratory capacity to improve diagnosis and treatment.
Researchers at the University of Liège uncover a mechanism regulating the immune response against parasites, where virtual memory T cells express CD22 to prevent excessive inflammation. This discovery opens new perspectives on controlling immune responses and mitigating autoimmune diseases.
Researchers found positive correlations in susceptibility to viruses across diverse fruit fly species, suggesting a general pattern of resistance. The study's findings have implications for understanding viral evolution and predicting pandemics.
A new study reveals that 93.2% of pediatric allogeneic hematopoietic stem cell transplantation (HSCT) recipients experience infections post-transplant, with viral infections being the most common. The study identifies key risk factors and highlights the importance of personalized approaches in infection management.
A recent study published in Communications Biology reveals that the Sudan virus binds to human cells through a specific protein called NPC1, which enables it to attach with nine times greater affinity than Ebola. This discovery may contribute to the high fatality rate of the Sudan virus.
Researchers developed a powerful tool to detect SARS-CoV-2 variants with high transmission potential, pinpointing exact mutations driving spread. The model focuses on spike protein and other parts of the virus, enhancing ability to bind human cells and evade immune systems.
Researchers at the University of Queensland have identified a new henipavirus, Camp Hill virus, in shrews in Alabama, USA. The discovery suggests these viruses may be more globally distributed than previously thought, with implications for human health and vaccine development.
Researchers at La Jolla Institute for Immunology discovered that tissue-resident memory CD8 T cells rise up to fight infections in the small intestine, using spatial transcriptomics technology. These immune cells are split between villi and crypts, with progenitor-like cells replenishing effector T cells.
The COMBINE project focuses on the critical virus-cell binding step, aiming to identify key factors and potential therapeutic targets involved early in viral infections. The team will use a combination of pioneering approaches to develop novel inhibitors and vaccine candidates.
Researchers at Harvard Medical School and Boston University have mapped the structure of the Nipah virus's polymerase complex, a key piece of its machinery. This discovery provides a detailed understanding of how the pathogen multiplies inside hosts and could inform the design of treatments.
Researchers analyzed data from a nationwide survey to understand the relationship between COVID-19 infection experiences and fear levels. The study found that mild infection experiences alleviated fear, while severe symptoms worsened it, and that fear decreased over time.
Researchers have identified the pathogens and diagnostic tests for the two diseases, revolutionizing cassava disease management in Latin America, the Caribbean, and Southeast Asia. The study, published in peer-reviewed journals, marks a significant milestone in fighting the spread of these devastating diseases.
Researchers found that a lower CD4+/CD8+ T cell ratio after 12-24 weeks significantly predicted HBsAg clearance in IHCs treated with peginterferon alpha. Higher baseline percentages of CD3+CD8+ cells and lower CD4+/CD8+ ratios were also associated with improved outcomes.
Researchers from UNIGE-HUG Centre and MSF successfully demonstrated the effectiveness of a hepatitis E vaccine in an outbreak in Bentiu, South Sudan. The study showed that two doses of the vaccine reduced the incidence of the disease and provided protection against severe symptoms.
Researchers document five cases of parvovirus B19-induced myocarditis in preschoolers from northern Greece, highlighting the virus's unique impact on endothelial cells. The study emphasizes the importance of quick diagnosis and treatment to reduce mortality and morbidity in children.
Researchers at Indiana University found that bacteria secrete molecules, like coelechelin, which weaken competitors' immune systems and increase their vulnerability to phage infection. This discovery highlights the potential of phage-chemical combinations in treating antibiotic-resistant infections.
Researchers at the University of Gothenburg have discovered an antibody-like molecule, E10, that can protect mice from various influenza viruses. The molecule targets a conserved part of the virus's surface protein shared across multiple influenza types, providing effective protection against seasonal epidemics.
Stephania Cormier and colleagues lead a Frontiers in Immunology research collaboration to explain RSV's complex interplay with host immune responses. The team identifies gaps in knowledge, hindering therapeutics and vaccines development.
A new study by La Jolla Institute for Immunology researchers suggests that many people may already have immune cells on standby to combat the H5N1 virus. The study found similarities between H5N1 and seasonal influenza viruses, allowing scientists to predict cross-reactive T cell responses that could help decrease disease severity.
According to a new survey, over half of U.S. adults believe the RSV vaccine is effective in protecting infants from the virus, up from 42% last year. The rise in perceived effectiveness comes as several politicians have cast doubt on the vaccine's safety and efficacy.
Researchers found that cellular RNA molecules help regulate antiviral signaling by activating the MAVS signalosome. This signaling pathway is crucial for coordinating immune responses against virus invasion. The study's findings suggest a potential role for RNA-based therapeutics in combating infections and autoimmune diseases.
A live-attenuated vaccine against Lassa virus has been developed and shown to be safe and 100% effective in protecting guinea pigs from the virus. The vaccine was created by modifying the genome of the virus to prevent it from causing disease, making it a promising candidate for future clinical trials.
Recent studies suggest HBV infection is associated with liver cancer stem cells, but the exact mechanisms are unclear. This study investigates the role of HBV infection in regulating the stemness of HCCs and its link to drug resistance.
The study analyzed the high burden of RSV-associated acute respiratory illness among young children in the U.S. and found nirsevimab to be effective against severe cases, highlighting the potential for substantial public health impact through increased prevention coverage.
Researchers discovered that BKPyV's large tumor antigen is expressed after the first round of cellular DNA replication, suggesting new drug targets to prevent kidney transplant failure. The study offers a possible solution by targeting host proteins required for re-replication, reducing the likelihood of virus resistance.
Researchers discovered a single mutation in the H5N1 virus that improves its ability to attach to human cells, potentially making it easier for humans to become infected. The study's findings stress the importance of continued genomic surveillance and public health preparedness to monitor potential genetic changes.
A UK study reveals a software tool increased child vaccinations by over 1,000; healthcare professionals praise digital tool's impact on timely vaccination. The 'APL-Imms' tool uses data to identify due vaccinations and helps reduce vaccine-preventable diseases.
Infectious disease experts suggest that hospitals closely monitor local and national cases of bird flu and screen patients with flu-like symptoms for contact with farm animals. Effective communication is essential for fostering trust and reducing anxiety among healthcare personnel, patients, and the public.